After a Bachelor’s Degree in Biotechnology at Trento University (Italy), Diego completed a Master’s Degree and PhD in Nanoscience at Aarhus University (Denmark). The aim of his PhD was to establish human serum albumin as platform for drug delivery in cancer immunotherapy. In 2024, Diego joined the Chappell group Rapid Response Vaccine Pipeline as Senior Research Assistant
Industry
Collaborations
Funding
Key Publications
Pilati, D., & Howard, K. A. (2020). Albumin-based drug designs for pharmacokinetic modulation. Expert Opinion on Drug Metabolism & Toxicology, 16(9), 783–795. https://doi.org/10.1080/17425255.2020.1801633
Anders Dinesen, Veronica L. Andersen, Marwa Elkhashab, Diego Pilati, Pernille Bech, Elisabeth Fuchs, Torbjørn R. Samuelsen, Alexander Winther, Yunpeng Cai, Anders Märcher, Archie Wall, Marjan Omer, Jesper S. Nielsen, Vijay Chudasama, James R. Baker, Kurt V. Gothelf, Jesper Wengel, Jørgen Kjems, and Kenneth A. Howard Bioconjugate Chemistry 2024 35 (2), 214-222 DOI: 10.1021/acs.bioconjchem.3c00491